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Abstract 
Complement receptor type 3 (CR3)-mediated cellular responses in guinea pig macrophages were investigated by using zymosan and serum- 
opsonized zymosan (SOZ) as the multivaIent ligand for CR3. The ingestion ofzymosan and SOZ was accompanied by 0; generation and arachidonate 
release. These responses were suppressed by prior exposure of macrophages to pertussis toxin (PT). Opso~t~on of zymosan gave rise to more than 
S-fold activation of the ingestion, whereas the magnitude of either arachinonate release or Oi_ generation was unchanged. The Fab’ fragment of 
anti-Z-l, a monoclonal antibody specific for the a chain of guinea pig CR3, inhibited the ingestion of zymosan by 60% without affecting zymosan- 
induced arachidonate release and 0; generation. These data suggested that there might be at least two f~nctjon~ly ~s~nct bmding sites for zymosan. 
0; generation and arachidonate release might be regulated through one site and phagocytosis another. Both sites should be coupled to PT-sensitive 
GTP binding protein. 
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1. I&rod&ion 
CR3 is a well known leukocyte intern and acts as the 
specific receptor for C3bi [l-3]. In addition, CR3 is in- 
volved in leukocyte adherence functions su4.1 as cell 
spreading on plastic surfaces, granulocyte aggregation, 
and chemotaxis [4,5]. CR3 further has &tin-like proper- 
ties of binding to zymosan and bacteria that lack fixed 
C3bi [6,7]. 
In previous studies, we have prepared a monoclonal 
antibody, named anti-Z- 1, which effectively inhibits 
phagocytosis of zymosan and SOZ by guinea pig macro- 
*Corresponding author. Fax: (81) (1332) 31669. 
**Preaerrf ad&ers: Ui laboratory3 The fnstitute of Physicat and Chem- 
ical Research, Wake-shi 351-01, Japan. 
Abbreviations: CR3, complement receptor type 3; C3bi, C3b treated 
with C3b inactivator; SOZ, serum-opsonized zymosan; PT, pertussis 
toxin; PMA, phorbol-It-myristate-l3-acetate; fMLP, formyl-Met-Leu- 
Phe; BSA, bovine serum albumin; KRH, Krebs-Ringer HEPES; E, 
sheep red blood ceil; EIgG, E coated with rabbit anti-sheep red blood 
cell; LF.4-1, leukocyte function associated protein-l, C kinase; protein 
kinase C. 
phages [S]. The Z-1 antigen consists of an a-chain of 140 
kDa non-covalently associated with a/?-chain of 95 kDa, 
Recently, the Z-1 antigen has been identified as the 
guinea pig homologue of human CR3 f&9]. The rationale 
for the identification is as follows: (i) the Z-l antigen is 
predo~nantly expressed on macrophages and granulo- 
cytes and is involved in zymosan-phagocytosis, as is 
human CR3, (ii) anti-Z-1 binds to the tl chain of human 
CR3, (iii) the /I subunit of the Z-l antigen is shared by 
two other surface antigens on guinea pig leukocytes that 
have their own unique Q subunit (Nochi et al., in prepa- 
ration), presumably the homoiogues of human LFA-1 
and gp150, 95, respectively [IO]. 
The expression of CR3 as well as the phagocytic ca- 
pacity associated with CR3 is reported to be increased 
by C kinase [11,12f, We have previously found that C 
kinase-induced phosphorylation of CR3 (8) resulted in 
down-regulation of CR3-mediated phagocytosis [13]. 
Regulation of CR3-mediated responses by surroundings 
has been well characterized but the signalling pathways 
arising from stimulation of CR3 itself have not been 
clarified. To identify the CR3 signal transduction, the 
inhibitory effect of a monoclonal antibody to the recep- 
tor on zymosan-induced responses was examied. PI’, 
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which blocks agonist-induced responses by causing 
ADP-ribosylation of mediating GTP-binding proteins 
[14], was simultaneously examined. It was demonstrated 
that a PT-sensitive GTP-binding protein is involved in 
CR3-mediated responses in guinea pig macrophages. 
The anti-CR3 antibody distinguished the pathway in- 
volved in zymosan-induced phagocytosis from that for 
0; generation. 
2. Materials and methods 
2.1. materials 
FT was purified from the 2-day culture su~~atant of Bordete~~a 
pertwssis [15]. Zymosan, PMA, fMLP, cytochalasin B, cytochrome c, 
and BSA (fatty acid free) were purchased from Sigma, [3H]ara- 
chidonate, Na”‘I, Na,s’CrO,, from New England Nuclear, and the GIT 
medium from Wako Chemical Co. (Tokyo). 
2.2. Preparation of macrophages 
Hartley guinea pigs weighing approximately 500 g were injected 
intraperitoneally with 20 ml of sterile thioglycollate broth 4 days before 
the collection of the exudate [8,13]. The &lls in the exsudate were 
collected in the Krebs-Rinaer HEPES (KRH) consistina of 134 mM 
NaCl, 4.7 mM KCl, 1.2 mM KH,PO,, I .i mM’MgSO,, 13 mM CaC&, 
0.1% BSA, 5 mM glucose, and 10 mM HEPES (pH 7.4). The cells were 
washed twice with KRH and finally suspended in the GIT medium at 
the con~ntration of IO’ cells/ml. Cells were then seeded at the density 
of 2 x 10’ cells/cm* in tissue culture wells and cultured at 37°C for 4 h 
in a humidified atmosphere containing 5% COz. Where indicated, the 
culture medium was supplemented with PT or [‘Hlarachidonate (0.1 
#.Ywell). After this 4-h culture period, the non-adherent cells were 
removed by three times washing with KRH and monolayers of adherent 
cells were used as macrophages for measurements of 0; generation, 
arachidonate release and phagocytosis. 
2.3. Preparation of mo~ocional anti-guinea pig CR3 
A mouse monoclonal anti-Z-1 antibody that recognizes the 61 subunit 
of guinea pig CR3 was purified from ascites fluid and its Fab’ fragment 
was prepared, as previously described [8]. 
2.4. Preparation of ‘251-labeled zymosan 
Zymosan was labeled with Nalz51 by the chloramine T method as 
previously described [131. The labeled zymosan was washed five times 
with PBS, and dialyzed for 4 days with eight changes of 1,000 ml of PBS 
containing 10 mM KI. After dialysis, the zymosan was pelleted, 
washed, and stored in PBS at a concentration of 5 mg/rnl at -20°C. 
2.5. Preparation of serum-opsonized zymosan (SOZ) and EIgG 
‘*?-Labeled or unlabeled zymosan A prepared as above was incu- 
bated with freshly prepared guinea pig serum (10%) at 37°C for 30 min 
and washed three times with KRH immediately before use. 
Sheep red blood cells (E) were labeled with “Cr and incubated with 
rabbit anti-E antibody as previously described [13,16]. 
2.6. 0; generation 
0; generation was determined by measuring the superoxide dis- 
mutase-inhibitable r duction of cytochrome c [17]. The macrophage 
monolayers were preincubat~ in KRH at 37°C for 10 mm and then 
fortified with PMA, fMLP, zymosan or SOZ together with cytochrome 
c (100 PM). Where indicated, the preincubation medium was fortified 
with monoclonal anti-CR3 antibody, anti-Z-l. After a 20-min incuba- 
tion, the incubation medium was withdrawn to be determined for 
changes in absorbance of cytochrome c (550-540 nm). 
2.7. Arachidonate release from r3~~arac~ido~te-~be~ed cells . __ 
[3H~ra~hidonate-la~led macrophage monolayers were preincu- 
bated in KRH at 37°C for 10 min and then incubated with zvmosan 
or SOZ for 20 min. Where indicated, the preincubation medium was 
supplemented with anti-Z-l. The radioactivity of ‘H released from the 
cells was measured as arachidonate release [18]. 
2.8. Phagocytosis of target cells 
~acrop~ge monolayers in GIT medium were incubated with 
(“51]zymosan, [‘251]SOZ, or “Cr-EIgG at 37°C in a CO,-incubator for 
60 min. For the assay of zymosan or SOZ phagocytosis, the cells were 
vigorously washed four times with PBS, which was withdrawn each 
time to remove free particles [13]. For the assay of EIgG phagocytosis, 
macrophage monolayers were washed twice with PBS, then exposed to 
l/S diluted hypotonic PBS for 30 s, and further washed twice with PBS 
to remove the EIgG bound at surface receptors 1191. These cells were 
finally solubilized with 2% Na,CO,/O. 1 N NaOH and the cell-associated 
radioactivity was measured in a autogamma counter. 
3. Results 
3.1. rnhibition ~ff~~P- or ~ymosan-induced 0; 
generation by prior exposure of macrophages to PT 
As reported earlier, PMA, fMLP or zymosan stimu- 
lated 0; generation in macrophages. fMLP- or zymosan- 
induced 0; generation was almost totally suppressed by 
the prior treatment of the cells with PT (Fig. 1). On the 
other hand, PMA~indu~d 0; generation was not af- 
fected by the PT treatment. The inhibitory effect of PT 
was dependent on the concentration of the toxin bin the 
culture medium. It has been well documented that the 
fMLP receptor is associated with a PT-sensitive GTP 
binding protein [18,20,21]. Since the degree of the inhibi- 
tion of 0; generation by PT was indistinguishable be- 
tween fMLP- and zymosan-treated cells at any PT con- 
centration, zymosan receptor should be also coupled 
with the GTP-binding protein. 
3.2. Inhibition o~zymos~n or SOZ ingestion by prior 
treatment of macrophuges with PT 
Zymosan has been demonstrated to bind to CR3 [6]. 
Opsonization of zymosan with fresh serum gives C3bi- 
coated zymosan (SOZ) which is a more efficient ligand 
of CR3. To determine CR3-dependent phagocytosis 
quantitatively, ‘251-labeled zymosan and [‘2sI]SOZ were 
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Fig. 1. Inhibitory effect of PT on fMLP- and zymosan-induced 0; 
production. Macrophages cultured with increasing concentration of PT 
were incubated with 1 mg/ml zymosan (a), 0.1 pM fMLP (cl), or 0.1 
,uM PMA (n) for 20 min. 0; production was measured by the reduction 
of cytochrome c. 0; production in untreated cells were 36.6 nmoY 
5 x 16cells for zymosan, 105.6 for fMLP, and 267.1 for PMA. 
Results were expressed as the percentage of these control value. Each 
point is the mean of duplicate observations in a typical experiment 
which was repeated more than three times essentially the same results. 
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Fig. 2. Inhibitory effect of PT on phagocytosis of zymosan or SOZ by 
macrophages. Macrophages were first cultured with (shaded bar, 100 
&ml) or without (open bar) PT for 4 h and then incubated with 
[‘ZSI]zymosan (A), [“‘I]SOZ (B), or “Cr-EIgG (C) for 60 min. Phagocy- 
tosis of these particles were expressed as percentage of total radioactiv- 
ity added to the macrophages. Each bar shows the mean f S.E.M. from 
triplicate observations in a typical experiment. 
prepared and added to macrophage monolayers. Opson- 
ization of zymosan gave rise to a more than 6-fold activa- 
tion of the ingestion (Fig. 2). Both zymosan and SO2 
phagocytoses were inhibited by the prior treatment of 
macrophages with PT. In contrast, the ingestion of anti- 
body-sensitized sheep E, which binds to Fc receptor, was 
never inhibited by the PT treatment (Fig. 2), making it 
unlikely that PT susceptibility is a general event associ- 
ated with particle ingestion. Together with the results 
shown in Fig. 1, CR3 should be coupled to a PT-sub- 
strate GTP-binding protein. 
3.3. Inhibition of zymosan- or SOZ-induced arachidonic 
acid release and 0; generation by prior exposure of 
macrophages to PT 
Both zymosan and SOZ induced arachidonic acid re- 
lease as well as 0, generation (Fig. 3). These responses 
increased in a manner similarly dependent on the con- 
centration of particles added. Both effects were markedly 
suppressed or mostly abolished by PT regardless of the 
concentrations of zymosan or SOZ. Apart from their 
differential effects on phagocytosis, both zymosan and 
SOZ caused essentially the same degree of increase in 
arachidonic acid release and 0; generation. The data 
would suggest hat these particles were ingested via the 
C3bi binding site of CR3 whereas arachidonate release 
and 0, generation were activated through a different 
binding site of the receptor. 
3.4. CR3-dependent stimulation of phagocytosis and 
CR3-independent stimulation of arachidonate release 
and 0; generation by zymosan 
Macrophages were preincubated with Fab’ of anti-Z-l 
that is specific for the 01 subunit of guinea pig CR3 and 
then supplemented with zymosan. Ingestion of zymosan 
was inhibited markedly by the antibody fragment with 
the maximal degree of inhibition of 60% (Fig. 4). In 
contrast, zymosan-induced arachidonate release and 0; 
generation was hardly inhibited by the antibody. To- 
gether with the results shown in Fig. 3, zymosan particles 
were ingested through the C3bi-binding site of CR3, 
which was also an anti-Z-l-susceptible site on CR3. In 
contrast, zymosan-induced arachidonate release and 0, 
generation occurred through anti-Z-l-insusceptible site 
on CR3 or through other undefined receptor(s) for zy- 
mosan. At least two functionally distinguishable recep- 
tors were operative in the activation of macrophages by 
zymosan. Both were regulated through PT-sensitive G 
protein. 
4. Discussion 
4.1. CR3-dependent and -independent responses of 
macrophages to zymosan stimulation 
CR3 plays a central role in host defence against micro- 
organisms ince, in many cases, bound C3b is converted 
Zymosan (mg/ml) SOZ ( mglml) 
Fig. 3. Dose-response curves for zymosan and SOZ effects on 0; 
production and arachidonate release in PT-treated or non-treated mac- 
rophages. Macrophages were cultured with [‘Hlarachidonate in the 
presence (0) or absence (0) of 100 ng/ml of PT for 4 h. The cells twice 
washed were incubated for 20 min with increasing concentration of 
zymosan (A,C) or SOZ (B,D). 0; production was measured by the 
reduction of cytochrome c (A,B). The radioactivity released into the 
medium is measured as arachidonate release (C,D) as described in 
section 2. Each point is the mean of duplicate observations in a typical 
experiment. Similar results were obtain in repeated experiments. 
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Fig. 4. Effect of anti-CR3 antibody on phagocytosis, arachidonate 
release, and 0; production in macrophages. Macrophages were cul- 
tured with (0) or without (-3, l ) [jH]arachidonate for 4 h. The cells 
washed twice were treated with increasing concentrations of Fab’ of 
monoclonal anti-Z-l for 15 min and then incubated with 1 mg/ml of 
zymosan for 20 min for arachidonate release (o), for 0; production (0) 
or for phagocytosis of [‘251]zymosan (1 mg/ml) for 60 min (0). Each 
point shows the mean value + S.E.M. from three observations in a 
typical experiment. Error bars are within the size of symbols in some 
cases. 
to C3bi on the surface of the foreign materials [22]. SOZ 
is also considered to be a ligand of CR3 because M-87% 
of the bound C3 consists of C3bi [23]. Furthermore, 
unopsonized zymosan as well as microorganisms uch as 
yeast and virulent pneumococci directly bind to CR3 
[6,24,25]. In guinea pig, the regulatory system for the 
cleavage of the complement C3b is almost identical with 
that in humans [26,27]. Our data in this communication 
suggest hat there might be at least two functionally dis- 
tinct binding sites for zymosan in guinea pig macroph- 
ages. One would be a C3bi-binding site, which is occu- 
pied by anti-Z-l, and mediate phagocytosis only. 
Another putative binding site (referred to henceforth as 
Rz) should be involved in arachidonic acid release and 
0; generation. Experimental supports for this assump- 
tion are as follows. (i) Opsonization of zymosan caused 
a 6-fold activation of the ingestion without increasing 0; 
production and arachidonate release. (ii) An antibody 
against guinea pig CR3 inhibited only zymosan phagocy- 
tosis without inhibition of accompanying 0; production 
or arachidonate release. 
4.2. Possible involvement of a GTP-binding protein in 
CR3-dependent and -independent process of zymosan 
stimulation 
It is now widely accepted that occupancy of fMLP 
receptors in leukocytes is coupled to activation of phos- 
pholipase C via a GTP-binding protein [18,20,21]. PT 
causes ADP-ribosylation of GTP-binding proteins and 
blocks fMLP-induced inositol phosphate formation. The 
dose and time required for PT treatment of macrophages 
to inhibit zymosan-induced 0; generation, arachidonic 
acid release, and phagocytosis were almost the same as 
those required to inhibit fMLP-induced responses. 
Hence, we could be convinced of the involvement of 
GTP-binding proteins in zymosan-induced activation of 
macrophages. The fact that PT inhibited not only 0; 
production but also phagocytosis might indicate the cou- 
pling of GTP-binding protein(s) with both C3bi-binding 
site and Rz. Recently, we found that spreading of macro- 
phages to plastic dishes was dramatically inhibited by PT 
(in preparation) and that tyrosine phosphorylation of 
~125~*~, a tyrosine kinase presumably associated with 
cell adhesion molecule, was dramatically decreased in 
PT-treated cells (unpublished data). These findings are 
suggestive of functional connection of a GTP binding 
protein with cell adhesion molecules like CR3. 
It has been believed that phagocytosis is accompanied 
by other microbiocidal mechanisms uch as superoxide 
production and vesicle degranulation. However, under 
the special conditions, superoxide production and de- 
granulation were demonstrated to occur independently 
of phagocytosis [28,29]. Our data in this paper suggest 
that phagocytosis and the other responses do not always 
occur by one and the same mechanism, although these 
immuno-inflammatory responses might be functionally 
related to each other. 
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